Shandong Sanyuan Biotechnology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE100005774
CNY
22.41
-0.7 (-3.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
224.78
173.43
158.11
167.76
150.20
197.98
138.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
224.78
173.43
158.11
167.76
150.20
197.98
138.08
Raw Material Cost
187.32
147.88
144.50
135.80
126.30
171.82
124.27
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
9.97
6.99
8.03
8.74
8.46
7.81
6.59
Other Expenses
0.82
0.89
0.92
0.37
0.84
0.54
0.39
Total Expenditure (Excl Depreciation)
205.53
163.73
161.78
148.26
143.17
185.06
134.72
Operating Profit (PBDIT) excl Other Income
19.2
9.7
-3.7
19.5
7
12.9
3.4000000000000004
Other Income
9.51
18.43
15.55
20.07
22.18
30.02
27.29
Operating Profit (PBDIT)
27.50
45.53
29.34
56.90
46.62
59.57
47.38
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
1.95
0.37
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
37.46
25.55
13.61
31.96
23.91
26.16
13.81
Depreciation
0.00
18.54
18.54
18.23
18.23
17.46
17.46
Profit Before Tax
29.45
27.35
10.80
38.67
28.39
42.11
29.92
Tax
3.36
3.65
1.24
6.23
3.02
18.52
0.77
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
26.09
24.01
9.92
32.57
24.91
23.94
29.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
26.09
24.01
9.92
32.57
24.91
23.94
29.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-0.09
-0.02
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26.09
24.01
9.92
32.48
24.89
23.94
29.09
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,265.06
4,239.13
4,314.96
4,305.15
4,492.24
4,491.21
4,527.05
Earnings per share (EPS)
0.13
0.12
0.05
0.16
0.12
0.12
0.14
Diluted Earnings per share
0.13
0.12
0.05
0.16
0.12
0.12
0.14
Operating Profit Margin (Excl OI)
8.01%
4.93%
-3.0%
11.08%
4.14%
6.11%
1.91%
Gross Profit Margin
13.1%
26.46%
18.56%
33.92%
31.04%
30.09%
34.31%
PAT Margin
11.61%
13.84%
6.27%
19.41%
16.59%
12.09%
21.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 49.67% vs -21.73% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 4.82% vs 2.89% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -26.23% vs 151.55% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Shandong Sanyuan Biotechnology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
224.78
0
224.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
224.78
0
224.78
Raw Material Cost
187.32
0
187.32
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
9.97
0
9.97
Other Expenses
0.82
0.00
0.82
Total Expenditure (Excl Depreciation)
205.53
0
205.53
Operating Profit (PBDIT) excl Other Income
19.25
0.00
19.25
Other Income
9.51
0
9.51
Operating Profit (PBDIT)
27.50
0
27.50
Interest
0.00
0
0.00
Exceptional Items
1.95
0
1.95
Gross Profit (PBDT)
37.46
0
37.46
Depreciation
0.00
0
0.00
Profit Before Tax
29.45
0
29.45
Tax
3.36
0
3.36
Provisions and contingencies
0
0
0.00
Profit After Tax
26.09
0
26.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
26.09
0
26.09
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26.09
0
26.09
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,265.06
0
4,265.06
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
8.01%
0%
0.00
8.01%
Gross Profit Margin
13.10%
0%
0.00
13.10%
PAT Margin
11.61%
0%
0.00
11.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 22.48 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 29.64% vs 9.68% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 49.67% vs -21.73% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.61 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.75% vs 142.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.82% vs 2.89% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -33.58% vs 96.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -26.23% vs 151.55% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.01%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025